Ependymoma Completed Phase 1 Trials for Veliparib (DB07232)

Also known as: Brain Ependymoma / Ependymoma of Brain / Ependymomas / Ependymoma (morphologic abnormality) / Ependymoma (disorder) / Ependymoma of brain (disorder)

IndicationStatusPhase
DBCOND0017183 (Ependymoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00994071A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS TumorsTreatment